M. Kathleen Behrens, Director at Sarepta Therapeutics, Inc. (SRPT), sold 10,000 shares at $131.71 ($1.3M) on 2018-10-31, disclosed to the SEC on 2018-11-02.
Open-market sale of $1.3M SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IGMS | BUY | 2022-04-04 | $1.4M | — | Filing → |
| SRPT | SELL | 2021-03-10 | $429K | — | Filing → |
| IGMS | BUY | 2020-12-15 | $3.0M | — | Filing → |